Business
Cartography Biosciences Announces Strategic Investment From Samsung Ventures to Advance Oncology Pipeline
SOUTH SAN FRANCISCO, Calif. & SEOUL, South Korea, May 06, 2026--Cartography Biosciences and Samsung Ventures today announced a strategic investment to support the advancement of Cartography’s differentiated oncology pipeline and expand its proprietary drug discovery platform.
About this update from Samsung Biologics Co., Ltd.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1836,"height":224,"url":"https://media.zenfs.com/en/business-wire.com/821dc9f8d524066c7cb4ffeb949014e4"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/5w1XYbvne.u.0pKPIfUcew--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTExNw--/https://media.zenfs.com/en/business-wire.com/821dc9f8d524066c7cb4ffeb949014e4","width":960,"height":117},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/syULtZnu02TX0B4v6_EjnQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTc4/https://media.zenfs.com/en/business-wire.com/821dc9f8d524066c7cb4ffeb949014e4","width":640,"height":78},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/XRPeY7TMI9GZ.32JBXA5_Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0yOTI-/https://media.zenfs.com/en/business-wire.com/821dc9f8d524066c7cb4ffeb949014e4","width":1200,"height":146}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1667,"height":272,"url":"https://media.zenfs.com/en/business-wire.com/b92d23c756f11bd26d0f3f322d6d15d0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Bm1XVy4OC2jYIbZTyG3rlw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE1Nw--/https://media.zenfs.com/en/business-wire.com/b92d23c756f11bd26d0f3f322d6d15d0","width":960,"height":157},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/kIqlBPW.ZDPoWcgjq8ktPQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTEwNA--/https://media.zenfs.com/en/business-wire.com/b92d23c756f11bd26d0f3f322d6d15d0","width":640,"height":104},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/Q3xD0ISlNGX7uYYrtkFWYQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0zOTI-/https://media.zenfs.com/en/business-wire.com/b92d23c756f11bd26d0f3f322d6d15d0","width":1200,"height":196}}},{"type":"text","content":"– Investment highlights growing interest in Cartography’s oncology pipeline and platform –","length":90,"tagName":"p","attribs":{}},{"type":"text","content":"SOUTH SAN FRANCISCO, Calif. & SEOUL, South Korea, May 06, 2026--(BUSINESS WIRE)--Cartography Biosciences and Samsung Ventures today announced a strategic investment to support the advancement of Cartography’s differentiated oncology pipeline and expand its proprietary drug discovery platform.","length":297,"tagName":"p"},{"typ...